AKT1 and neoplasm: The c-Met tyrosine kinase receptor is implicated in the upstream pathways of PI3K/AKT and Ras/MAPK; it is overexpressed in 60–86% of solid tumors and associated with tumor aggressiveness in UM [30,45].